Overview

Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia

Status:
RECRUITING
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
To assess the 1-month effects and safety of esketamine combined PRF and standardized treatment to relieve pain in patients with acute/subacute zoster-related trigeminal neuralgia(ZRTN).
Phase:
NA
Details
Lead Sponsor:
Beijing Tiantan Hospital
Collaborators:
Beijing Ditan Hospital
Beijing Xiaotangshan Hospital
Hengshui People's Hospital
The First Hospital of Fangshan District,Beijing
Treatments:
Esketamine
Prolactin-Releasing Hormone